TAK logo

TAK Takeda Pharmaceutical Company Limited

New York Stock Exchange · Drug Manufacturers - Specialty & Generic · Healthcare

$21.46
+0.20 (+0.92%)

Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such a…

Market Cap: $68.58Bwww.takeda.com

Price

No data yet.

Social Signal Score

51
5d
—
30d
54
5 mentions
—
60d
52
7 mentions
—
90d
46
10 mentions
—
news: 10

Analyst Ratings

6 analysts
Buyconsensus
Strong Buy 0Buy 5Hold 1Sell 0Strong Sell 0

Revenue

$1.19T+155.26%
$400.96B$673.94B$946.92B$1.22T
Dec 2016Sep 2026

Analyst Estimates

FY2026
$71.80
$70.42–$72.71
1 analysts
FY2027
$68.00-5% YoY
$17.41–$85.96
2 analysts
FY2028
$104.96+54% YoY
$93.00–$112.93
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Julie So-Young Kim
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
47,029
Beta
0.09
Country
JP
Piotroski score
7 / 9 (Strong)
Altman Z-score
1.40
www.takeda.com